Nuclear Medicine Industry Seminar Held

In order to accelerate the independent research and development of key technologies in the field of nuclear medicine and health, and promote the standardized and leapfrog development of China's nuclear medicine industry, the Second High Quality Development Symposium of the Nuclear Medicine Industry, hosted by the Chinese Nuclear Society and the National Medical Isotope Industry Alliance, was held in Mianyang on December 8th. About 300 experts, scholars, and entrepreneurs from related fields attended the conference.

The nuclear medical industry has broad prospects, how can Sichuan catch up with this industry; Express train;? Experts are focusing their attention on the numerous research institutes within Sichuan province. Taking the Institute of Fluid Physics at the Chinese Academy of Engineering Physics as an example, the institute's research and development level in the field of nuclear technology applications ranks among the world's top. Relying on its technological advantages, Mianyang is accelerating the independent research and development of key core technologies in the field of nuclear medicine and the transformation of scientific and technological achievements.

At present, Mianyang has launched the construction of the Fujiang Laboratory focusing on the field of nuclear medicine, and has established a number of national and provincial innovation platforms such as the National Health Commission's Key Laboratory of Nuclear Technology Medical Transformation, the National Atomic Energy Agency's Nuclear Technology Research and Development Center, and the Key Laboratory of Targeted Radiopharmaceuticals Creation. At the same time, Mianyang has made pioneering progress in key core technology research and development. Currently, the largest medical cyclotron production base in China has been built in Mianyang, and the country's first high-power petal shaped accelerator with independent intellectual property rights has been successfully developed. Medical isotopes and drugs such as iodine-131 and lutetium 177 have achieved independent controllability.